FDA tells J&J to discard more batches of vaccine from Baltimore plant
The FDA has told Johnson & Johnson that more batches of COVID-19 vaccine produced at a plant under scrutiny for its manufacturing practices must be discarded. In a statement, the FDA said it determined “several” batches from the Emergent BioSolutions manufacturing facility in Baltimore “are not suitable for use.” It did not say how many doses of the country’s